The clinical suspicion of ARC Syndrome was confirmed through genetic analysis which showed two de novo mutations in the VPS33B gene: an heterozygous mutation (intron 16–17) c.1225 + 5G > Cp.()? Here, VPS33B is linked to arthrogryposis-renal dysfunction-cholestasis syndrome.